Albert Labs announces Strategic Investment from Cantheon Capital LLC for First In-Human TrialsMindMed Reports Full Year 2022 Financial Results and Business HighlightsCybin to Participate in the Oppenheimer 33rd Annual Healthcare ConferenceNuminus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023Braxia Scientific Provides Update on Proposed Irwin Transaction; Company Retains Strategic Clinical Assets and Ketamine Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023Irwin Naturals Signs Letter of Intent to Acquire Braxia ScientificNuminus Wellness Inc. Reports Q1 2023 ResultsIrwin Naturals and Braxia Scientific Announce Partnership for In-Human Clinical Studies Supporting Pharmaceutical CompanNuminus Develops Mushroom Tea for Use in Psychedelic ResearchIs the Psychedelic Sector Poised for a Comeback?!?PSYC + Nucleus Form New Partnership to Develop and Launch Psychedelic FinderWhat You Need to Know About Numinus Wellness…Numinus provides update on acquisition integration and announces new client financing optionsPSYC Corp’s Psychedelic Spotlight Surpasses One Million Page Views for Fourth Consecutive MonthNuminus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022The Psychedelic Sector is Quietly Outperforming the S&P 500PSYC Completes and Publishes 2021 Audited Financials; Will Begin Audit of Q1 & Q2 2022Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022PSYC’s Bonfire Platform Development Progresses; Will Host Free Virtual Community Event on August 29th

Emblem Corp. Are Coming To Florida

Apr 28, 2017 • 6:18 PM EDT
Trump (2).png
1 MIN READ  •  By Michael Berger
Share Share - Facebook Share - Twitter

One of the main reasons driving our bullish view on the Canadian cannabis industry is that medical cannabis is legal at the federal level.

Unlike what we have in the United States, Canadian cannabis companies can use banks and access basic business services allowing them to more efficiently operate. One of the companies we have been monitoring and favorable on is Emblem Corp (EMC.V) (EMMBF).

Attractive Operating Structure

Emblem is a licensed medical cannabis producer in Canada uniquely positioned within the rapidly growing medical and recreational cannabis industry. The company is focused on cannabis production through Emblem Cannabis, patient education through GrowWise Health, and pharmaceutical production through Emblem Pharmaceuticals.

We are very favorable on the company’s biotech focused initiatives and believe the market undervalues its potential. Emblem Pharmaceuticals President John Stewart is leading the launch of cannabinoid-based medications in customary pharmaceutical dosage forms such as liquids, gel caps, oral sprays, and inhalers.

Stewart has 30+ years experience developing and commercializing pharmaceutical products. He launched 11 new products (one of the most notable being OxyContin) while serving as the worldwide President and CEO of Purdue Pharma.

Meet with Emblem CEO on Monday in Miami

Emblem is led by its founders and a management team with a proven track record of success. Since inception, management has invested over $6 million in the company and executed flawlessly to create a world class facility with world class products.

On Monday, May 1st, investors interested in learning about Emblem Corp can meet with Emblem CEO Gordon Fox at American Social Bar and Grill in Miami, Florida.

Reach out to if you are interested in attending. The event is FREE to attend and food and drinks will be provided.


Share Share - Facebook Share - Twitter


Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners, LLC and Founder of Prior to entering the cannabis industry, Michael was an Equity Research Analyst at Raymond James Financial covering the Energy Sector. Michael has been featured in publications such as The Street, Bloomberg, US Money News, and hosts various cannabis events across North America.


Top Stories

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Mushroomstocks newsletter.

 All good -- no spamming here.

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.